SynuCa Therapeutics: Funding, Investors & Team (Sep 2026)
Synuca Therapeutics focused on developing innovative therapies for neurological disorders, particularly Parkinson's disease.
SynuCa Therapeutics has raised $1.5M across 1 funding round on record, the most recent a Seed of $1.5M announced in Mar 2026.
That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
SynuCa Therapeutics Company Profile and Key Stats
Latest funding round on record: Mar 2026.
SynuCa Therapeutics Funding Rounds
SynuCa Therapeutics Founders and Leadership Team
Contact details for the SynuCa Therapeutics team: 1 of 1 has an email address on file, 1 has a LinkedIn profile.
Start 14-day free trial →SynuCa Therapeutics Funding Compared to Other Biotechnology Startups
SynuCa Therapeutics' latest round of $1.5M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like SynuCa Therapeutics in Biotechnology and Aarhus
Companies Similar to SynuCa Therapeutics
Curasight is a biotech company focused on addressing the need for improved diagnosis and treatment of several…
Alcolase is a Danish life science start-up that specializes in alcohol flushing.
ADCendo ApS is a biotech company dedicated to developing new types of anti-cancer drugs. We focus on…
ENZIDIA is unleashing the biomanufacturing revolution with an enzyme acceleration revolution
Gefjon Pharma is a biopharmaceutical company focused on developing innovative solutions to combat…
Galecto develops small molecules for the treatment of severe diseases, including fibrosis and cancer. The…
Pioneering new sustainable bio-based ingredients
Muna Therapeutics is a private biopharmaceutical company that discovers and develops therapies that slow or…
EvodiaBio is a company in the bio-industrial sector that develops eco-friendly fragrances for the food and…
Fida Biosystems is a technology that provides the detection and characterization of proteins and…
Chromologics is a company that creates new and original food colorings utilizing natural ingredients. Derived…
WiLD is a networking platform for women in senior positions in business and academia that is motivating and…
SynuCa Therapeutics Funding FAQs
What does SynuCa Therapeutics do?
Synuca Therapeutics focused on developing innovative therapies for neurological disorders, particularly Parkinson's disease.
How much funding has SynuCa Therapeutics raised?
SynuCa Therapeutics has raised $1.5M across 1 round on record. The most recent is a Seed of $1.5M announced in Mar 2026.
When did SynuCa Therapeutics last raise funding?
SynuCa Therapeutics' most recent funding round on record is a Seed of $1.5M, announced in Mar 2026.
Who founded SynuCa Therapeutics?
FundedIQ lists Lasse Reimer (Founder) at SynuCa Therapeutics.
Where is SynuCa Therapeutics headquartered?
SynuCa Therapeutics is based in Aarhus, Midtjylland, Denmark.
How many employees does SynuCa Therapeutics have?
SynuCa Therapeutics is in the 1-10 employee band.
How does SynuCa Therapeutics' funding compare to other Biotechnology startups?
SynuCa Therapeutics' latest round of $1.5M is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's SynuCa Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for SynuCa Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.